Werewolf Therapeutics (HOWL)Director sold ~$28K
Luke Evnin, Director at Werewolf Therapeutics, sold ~$28K of Werewolf Therapeutics shares.
- ~$28K
- Approx. value · 77K sh @ $0.37
- 300K
- Holds after · shares reported
- Traded
- Jun 9, 2026
- Filed
- Jun 10, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 4, 2026InsiderDirector sold ~$35K of HOWL shares in the open market
- May 5, 2026InsiderDirector sold ~$4.7K of HOWL shares in the open market
- May 6, 2026InsiderDirector sold ~$9.7K of HOWL shares in the open market
- May 7, 2026Company filing · Form 8-K · ResultsReported its results
- May 7, 2026InsiderDirector sold ~$50K of HOWL shares in the open market
- May 8, 2026Insider · 2 peopleInsiders: 3 sales (~$481K)
- May 11, 2026Insider · 2 peopleInsiders: 3 sales (~$81K)
- May 12, 2026Insider · 2 peopleInsiders: 3 sales (~$108K)
- May 13, 2026InsiderDirector sold ~$24K of HOWL shares in the open market
- May 18, 2026InsiderDirector sold ~$11K of HOWL shares in the open market
- May 19, 2026InsiderDirector sold ~$28K of HOWL shares in the open market
- May 20, 2026InsiderDirector sold ~$37K of HOWL shares in the open market
- May 21, 2026InsiderDirector sold ~$15K of HOWL shares in the open market
- May 22, 2026InsiderDirector sold ~$39K of HOWL shares in the open market
- May 26, 2026InsiderDirector sold ~$32K of HOWL shares in the open market
- May 27, 2026InsiderDirector sold ~$39K of HOWL shares in the open market
- May 28, 2026InsiderDirector sold ~$13K of HOWL shares in the open market
- May 29, 2026InsiderDirector sold ~$15K of HOWL shares in the open market
- Jun 1, 2026InsiderDirector sold ~$38K of HOWL shares in the open market
- Jun 2, 2026InsiderDirector sold ~$13K of HOWL shares in the open market
- Jun 3, 2026InsiderDirector sold ~$12K of HOWL shares in the open market
- Jun 4, 2026InsiderDirector sold ~$8.8K of HOWL shares in the open market
- Jun 5, 2026InsiderDirector sold ~$10K of HOWL shares in the open market
- Jun 8, 2026InsiderDirector sold ~$24K of HOWL shares in the open market
- Jun 9, 2026 · this disclosureInsiderDirector sold ~$28K of HOWL shares in the open market
What came next
- Jun 9, 2026Insider · 1 personInsiders: 2 sales (~$137K)
- Jun 10, 2026Insider · 1 personInsiders: 2 sales (~$17K)
- Jun 11, 2026Insider · 1 personInsiders: 2 sales (~$100K)
- Jun 12, 2026Insider · 1 personInsiders: 2 sales (~$68K)
- Jun 15, 2026Insider · 1 personInsiders: 2 sales (~$50K)
- Jun 16, 2026Insider · 1 personInsiders: 2 sales (~$55K)
- Jun 17, 2026Insider · 1 personInsiders: 2 sales (~$146K)
- Jun 29, 2026InsiderDirector sold ~$47K of HOWL shares in the open market
- Jul 6, 2026InsiderDirector sold ~$11K of HOWL shares in the open market
- Jul 7, 2026InsiderDirector sold ~$33K of HOWL shares in the open market
- Jul 31, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 14, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Aug 21, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Werewolf Therapeutics
OQRO holds no insider, Congress, fund or contract record for Werewolf Therapeutics dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HOWL page.
Other recent filings by Luke Evnin, Director
- SEC Form 4 at Werewolf Therapeutics (HOWL)Jul 8, 2026
- SEC Form 4 at Werewolf Therapeutics (HOWL)Jul 8, 2026
- SEC Form 4 at Werewolf Therapeutics (HOWL)Jun 29, 2026
- SEC Form 4 at Werewolf Therapeutics (HOWL)Jun 8, 2026
- SEC Form 4 at Werewolf Therapeutics (HOWL)Jun 8, 2026
The full history of Luke Evnin, Director is on the profile page.
How this filing works
Other disclosures at Werewolf Therapeutics
- SEC Form 4Jul 8, 2026
- SEC Form 4Jul 8, 2026
- SEC Form 4Jun 29, 2026
- SEC Form 4Jun 22, 2026
- SEC Form 4Jun 22, 2026
- SEC Form 4Jun 16, 2026
Everything OQRO holds on this company is on its HOWL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
